NCT03108573

Brief Summary

This study evaluates different optimized MRI sequences for the detection of brain lesions in patients with multiple sclerosis in comparison with the recommended FLAIR sequence

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2012

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2013

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2017

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 11, 2017

Completed
Last Updated

April 11, 2017

Status Verified

March 1, 2017

Enrollment Period

8 months

First QC Date

March 16, 2017

Last Update Submit

April 5, 2017

Conditions

Multiple Sclerosis

Outcome Measures

Primary Outcomes (1)

  • Number of detectable lesions

    quantification of lesions on each sequence

    baseline

Secondary Outcomes (1)

  • localisation of lesions

    baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with a definite diagnosis of multiple sclerosis, with a follow-up MRI

You may qualify if:

  • relapsing remitting multiple sclerosis
  • MRI required

You may not qualify if:

  • MRI contraindication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2017

First Posted

April 11, 2017

Study Start

December 12, 2012

Primary Completion

July 31, 2013

Study Completion

July 31, 2013

Last Updated

April 11, 2017

Record last verified: 2017-03